Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
ayqxvQKUSvYvzH0N